What Are Interstitial Markings and What Do They Mean?

Interstitial markings are the fine lines and patterns visible on a chest X-ray or CT scan that represent the connective tissue framework of the lungs, including blood vessels, lymphatic channels, and the thin walls separating air sacs. On a normal chest image, these markings appear as delicate, branching lines radiating outward from the center of the chest. When a radiology report mentions “increased interstitial markings” or “interstitial opacities,” it means those normally subtle structures look thicker, denser, or more prominent than expected, which can signal anything from mild fluid buildup to serious lung disease.

What the Lung’s Interstitium Actually Is

Your lungs are not just hollow bags of air. Between the tiny air sacs (alveoli) where oxygen exchange happens and the blood vessels that carry that oxygen away, there is a thin scaffolding of tissue called the interstitium. This scaffold holds the lung’s shape and contains connective tissue fibers, small blood vessels, and lymphatic channels that drain fluid. On imaging, all of these structures together create the “interstitial markings” a radiologist reads.

In a healthy lung, the interstitium is so thin it is nearly invisible on a standard chest X-ray. You can see the larger blood vessels branching from the center of the chest toward the edges, but the finer tissue between air sacs does not show up unless something makes it swell, thicken, or fill with material that does not belong there. That is why a report noting “prominent” or “increased” interstitial markings gets attention: it suggests the interstitium has changed.

How Interstitial Markings Appear on Different Scans

A standard chest X-ray can pick up many interstitial changes, but it has limits. The diagnostic accuracy of a chest X-ray in suspected interstitial lung diseases is around 80%, and a chest X-ray can actually look normal in someone who has early disease.¹ That is why doctors often follow up with a high-resolution CT scan (HRCT), which slices the lung into thin cross-sections and reveals detail a standard X-ray misses.

On HRCT, interstitial patterns fall into recognizable categories. These include septal thickening (the walls between lung lobules becoming visible), reticular patterns (a net-like web of lines), ground-glass opacity (a hazy cloudiness that does not completely obscure the underlying structures), nodular patterns, cystic changes, and combinations such as “crazy paving,” where ground-glass haze overlaps with a visible network of thickened lines.² Each pattern narrows the list of possible causes, which is why radiologists describe them so precisely.

When a HRCT shows a pattern consistent with usual interstitial pneumonia (UIP), the hallmark of idiopathic pulmonary fibrosis, its positive predictive value reaches roughly 90 to 100%, meaning that imaging alone can sometimes clinch the diagnosis without a biopsy.¹ Not every pattern is that definitive, though, and many require additional testing to pin down.

Acute Causes of Increased Interstitial Markings

The most common reason you will see “increased interstitial markings” on an emergency-room chest X-ray is fluid where it should not be. Pulmonary edema occurs when fluid leaks out of blood vessels into the interstitium and, eventually, into the air sacs themselves. It can be driven by high pressure in the blood vessels (as in heart failure), by damage to the vessel walls (as in severe infection or inhaled toxins), or by a combination of both.³ On imaging, early fluid accumulation thickens the interstitial lines before the air sacs flood, so “increased interstitial markings” can be an early warning of worsening heart failure or fluid overload.

Infections can also produce interstitial patterns. Viral pneumonias, including COVID-19, frequently cause ground-glass opacities and interstitial thickening on CT. During the pandemic, CT scoring systems were developed specifically to quantify how much of the lung showed these interstitial changes, because the extent of involvement helped predict which patients would need intensive care.⁴ The key difference from edema is context: a patient with a fever and a cough whose scan shows bilateral ground-glass changes is evaluated very differently from a patient with known heart disease whose scan shows similar haziness.

Chronic Interstitial Lung Diseases

When increased interstitial markings are not explained by fluid or infection, doctors consider a broad group of conditions collectively called interstitial lung diseases (ILDs). These are chronic conditions in which the interstitium becomes inflamed, scarred, or both. The list of ILDs is long, but a few categories account for most cases.

Idiopathic pulmonary fibrosis (IPF) is the most well-known. “Idiopathic” means no identifiable cause has been found. On HRCT it typically shows a UIP pattern: honeycombing (clusters of small cysts) and reticular lines concentrated in the lower and outer portions of the lungs. Because the HRCT pattern is so distinctive, imaging alone is often enough for diagnosis, as noted above.

Autoimmune diseases are another major driver. Conditions like rheumatoid arthritis and systemic sclerosis (scleroderma) can attack the lungs. ILD shows up in up to 30% of patients with connective tissue diseases, and it is especially common in rheumatoid arthritis and systemic sclerosis.⁵ For these patients, the interstitial markings on imaging may be the first sign that their autoimmune condition has spread to the lungs, sometimes before they notice significant breathing problems.

Sarcoidosis deserves its own mention because its imaging pattern is unusual. Rather than the lower-lung reticular lines seen in IPF, sarcoidosis typically shows tiny nodules clustered along lymphatic pathways, fibrotic changes, and bilateral opacities near the center of the chest around the airways.⁶ That distinctive distribution helps radiologists distinguish sarcoidosis from other ILDs, though atypical presentations can still cause confusion.

Smoking and Interstitial Changes

You do not need a diagnosed lung disease to develop interstitial changes. Since widespread CT-based lung cancer screening began, radiologists have been spotting interstitial abnormalities in current and former smokers who have no respiratory symptoms at all. Early fibrotic changes such as reticulations, linear opacities, and subtle architectural distortion are frequently seen on HRCT in these screening populations.⁷

Cigarette smoke is a strong driver of lung inflammation, and two specific conditions are closely tied to heavy smoking: respiratory bronchiolitis-associated interstitial lung disease (RB-ILD) and desquamative interstitial pneumonia (DIP).⁸ Both involve inflammation and cellular buildup in the interstitium, and both can improve if the person quits smoking early enough. The catch is that many smokers have no idea anything is happening in their lungs until a screening CT reveals it, which makes the incidental discovery both concerning and, potentially, an opportunity for early intervention.

When Cancer Mimics Interstitial Disease

One of the more dangerous reasons for increased interstitial markings is lymphangitic carcinomatosis, a condition in which cancer cells spread into the lymphatic channels and surrounding tissue of the lungs. The tumor cells cause the interstitium to thicken, producing septal lines and reticular patterns on CT that can look strikingly similar to ordinary interstitial lung disease or even infection.⁹ That resemblance can delay the correct diagnosis.

The mechanism involves tumor cells reaching the lungs through the bloodstream, lodging in small vessels, and then migrating into the lymphatic system. Once there, the tumor triggers additional tissue reaction that further thickens the interstitial walls.¹⁰ On CT, the characteristic finding is nodular septal thickening, which was the dominant pattern in the vast majority of patients in one imaging study.¹¹ The cancers most commonly responsible include breast, lung, stomach, and prostate cancers. If a patient with a known malignancy develops new interstitial markings, lymphangitic carcinomatosis is high on the list of concerns.

Drug-Induced Interstitial Changes

Medications are an underappreciated cause of interstitial lung changes. Dozens of drugs can damage the lung’s interstitium, and the imaging patterns they produce overlap heavily with those of ILDs, making the connection easy to miss. Two of the best-documented culprits are amiodarone, a heart rhythm medication, and methotrexate, used for autoimmune conditions and certain cancers.

Amiodarone causes changes in respiratory function in roughly 4 to 6% of patients who take it, and when it does cause lung toxicity, the mortality rate can reach 20%. Methotrexate affects about 7% of patients on long-term therapy.¹² The HRCT patterns vary: some drugs cause ground-glass opacities, others produce organizing pneumonia or diffuse fibrosis. The critical step is recognizing that a medication could be the cause, because stopping the offending drug is often the most effective treatment. An online database called Pneumotox (maintained by a French research group) catalogues hundreds of drugs known to cause lung toxicity, and it is a go-to resource for clinicians puzzling over unexplained interstitial changes.

How Lung Function Tests Fit In

Imaging tells you what the lungs look like; lung function tests tell you how well they work. The two most important measurements in interstitial disease are the forced vital capacity (FVC), which reflects how much air your lungs can hold and push out, and the gas transfer factor (also called DLCO or TLCO), which measures how efficiently oxygen moves from the air sacs into the bloodstream.

Declining lung function carries real prognostic weight. In a large study of over 6,800 ILD patients, each unit decrease in the FVC score was associated with roughly a 10% increase in the risk of death, while each unit decrease in the gas transfer score was linked to an increase of more than 30%.¹³ That makes gas transfer the more sensitive predictor, which makes sense: if the interstitium is thickened or scarred, oxygen has a harder time crossing from air to blood, and that shows up in the gas transfer measurement before it shows up as a reduced lung volume.

Interestingly, some ILD patients show increased airflow speeds on breathing tests, even when their lung volumes and gas transfer look normal. In one study, an elevated ratio of air pushed out in the first second to total exhaled air was the most common abnormality among ILD patients whose other test results were still in the normal range, present in about 30% of cases.¹⁴ This happens because stiffened, fibrotic lung tissue pulls airways open more than healthy tissue does, allowing air to rush out faster. It is a counterintuitive finding: faster airflow sounds like it should be good news, but in this context it reflects stiffer lungs.

Incidental Findings and What Happens Next

A growing number of people learn about their interstitial markings by accident. CT scans done for other reasons, whether screening for lung cancer, evaluating a heart condition, or checking for kidney stones, increasingly turn up interstitial lung abnormalities (ILAs) that nobody was looking for. These are not the same as a diagnosed interstitial lung disease; they are early or subtle changes that may or may not progress.

Still, they are not harmless incidentals to shrug off. A systematic review and meta-analysis found that people with ILAs face a significantly higher risk of dying from any cause compared with people whose scans are clean, with the risk roughly two and a half times higher. They also have nearly four times the risk of developing lung cancer.¹⁵ For cancer patients specifically, having ILAs raises the risk of complications from radiation therapy and immunotherapy drugs.¹⁵

That does not mean every person with incidental ILAs needs aggressive treatment. A position paper from the Fleischner Society, a respected international radiology group, lays out a framework for deciding who needs monitoring and who does not. The key distinction is between ILAs that look fibrotic, especially those in the subpleural (near the lung surface) region, and those that look non-fibrotic and are more scattered. The fibrotic subtype is more likely to progress and to be linked to higher mortality.¹⁶

If you have no risk factors and no symptoms, the current guidance suggests you do not need routine follow-up imaging, but should return if you develop breathing problems. If you have risk factors, such as a smoking history, an autoimmune condition, or a family history of lung fibrosis, experts recommend a follow-up scan somewhere between 3 and 12 months after the initial finding.¹⁷

Occupational and Environmental Exposures

Workplace exposures remain an important and sometimes overlooked trigger for interstitial changes. Asbestos is the classic example: inhaled asbestos fibers lodge in the lungs and produce a slow-developing fibrosis called asbestosis, with characteristic thickened interstitial markings on imaging, often accompanied by pleural plaques on the lung lining. But asbestos is far from the only culprit. Silica dust (from mining, sandblasting, or stone cutting), coal dust, and certain metal dusts all cause their own forms of interstitial disease.

Hypersensitivity pneumonitis is another occupational condition worth knowing about. It results from repeated inhalation of organic particles, such as mold spores, bird proteins, or certain chemicals. In its chronic form, fine crackles are heard in about 90% of patients on lung examination, and finger clubbing appears in about 30%.¹⁸ The imaging pattern can resemble other ILDs, which is why an occupational history is so important. If a doctor does not ask what you do for work and what you are breathing in, the diagnosis can easily be missed, and removing the exposure is the single most effective intervention.

How Aging Affects Interstitial Markings

Not every prominent interstitial marking on an older person’s scan means disease. The lungs change with age in ways that are entirely normal but can look alarming on imaging if the radiologist is not careful. Connective tissue stiffens, small airways lose some of their elasticity, and subtle linear opacities may appear that do not represent active disease. Distinguishing these age-related changes from genuine pathology is essential to avoid putting patients through unnecessary biopsies, treatments, or anxiety.¹⁹

This is especially relevant given how many older adults now undergo CT scanning. A person in their seventies who gets a CT for an unrelated reason and receives a report mentioning “mild interstitial changes” may panic unnecessarily. Context matters enormously: the patient’s age, smoking history, symptoms, occupational exposures, and whether the pattern has changed over time all factor into whether those markings warrant further workup or simply a note in the chart. The radiologist’s job is not just to describe what they see but to interpret it in light of the whole clinical picture, and that interpretive step is where the real value lies.

Technical Artifacts That Mimic Real Disease

Before assuming that increased interstitial markings mean something is wrong, it is worth knowing that imaging artifacts can create false alarms. On a standard chest X-ray, simply taking the image with the patient slightly rotated, or capturing it during a shallow breath rather than a full inhalation, can make normal lung markings look abnormally prominent. Excess body tissue in obese patients can also create a hazy appearance over the lung fields that mimics interstitial disease.

On CT, motion artifacts from breathing or heartbeat can blur fine structures and produce spurious ground-glass opacity. Radiologists are trained to recognize these pitfalls, and mimics of true interstitial disease on HRCT are a well-documented phenomenon.² If your report mentions borderline interstitial changes and the radiologist recommends a repeat scan with better technique, that is a reasonable and common step before launching into a full disease workup. Getting the image right is the necessary first step before interpreting what it shows.